Literature DB >> 2059154

Inhibition of human and rabbit platelet aggregation by chlorophenoxyacid herbicides.

H A Elo1, T Luoma, P Ylitalo.   

Abstract

Inhibition of human platelet aggregation by eight chlorophenoxyacid herbicides was studied in vitro. Thrombocyte aggregation in the platelet-rich plasma was induced by 1.0-32.0 microM adenosine diphosphate (ADP), 0.32-32.0 microM adrenaline or 7.5-30.0 micrograms/ml collagen with and without chlorophenoxyacid (0.05-2.0 mg/ml). Platelet aggregation by each inducer was inhibited dose dependently by all the eight chlorophenoxyacids at concentrations between 0.1 and 2.0 mg/ml. Increasing the concentrations of ADP and collagen but not of adrenaline inhibited the antiaggregatory action of chlorophenoxy-acids. No essential differences in inhibitory effect were found between different chlorophenoxyacids varying in respect of their ring substituents and the length of the carboxylic side chain. In the platelet-rich plasma prepared from rabbits 2.5 h after subcutaneous injection of 2.4-dichlorophenoxyacetic acid or 4-chloro-2-methylphenoxyacetic acid (100-150 mg/kg), platelet aggregation by ADP was inhibited 20-30%, compared to plasma taken from the rabbits before the chlorophenoxyacid treatment. The inhibition had disappeared by 20-23 h after administration. The results indicate that chlorophenoxyacid herbicides inhibit human platelet aggregation. Furthermore, the inhibition is probably involved in haemorrhages known to occur in various tissues of animals intoxicated by chlorophenoxyacid herbicides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059154     DOI: 10.1007/bf02034941

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Toxicity of 2,4 dichlorophenoxyacetic acid for experimental animals.

Authors:  E V HILL; H CARLISLE
Journal:  J Ind Hyg Toxicol       Date:  1947-02

3.  Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.

Authors:  R L Kinlough-Rathbone; M A Packham; H J Reimers; J P Cazenave; J F Mustard
Journal:  J Lab Clin Med       Date:  1977-10

4.  Interrelations of platelet aggregation and secretion.

Authors:  I F Charo; R D Feinman; T C Detwiler
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

5.  Treatment of severe 2,4-D and mecoprop intoxication with alkaline diuresis.

Authors:  L F Prescott; J Park; I Darrien
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

6.  The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.

Authors:  K Stegmeier; J Pill; B Müller-Beckmann; F H Schmidt; E C Witte; H P Wolff; H Patscheke
Journal:  Thromb Res       Date:  1984-08-15       Impact factor: 3.944

7.  FATAL POISONING IN MAN BY 24-DICHLOROPHENOXYACETIC ACID (2,4-D): DETERMINATION OF THE AGENT IN FORENSIC MATERIALS.

Authors:  K NIELSEN; B KAEMPE; J JENSEN-HOLM
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

8.  Toxicity of 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid; a report on their acute and chronic toxicity in dogs.

Authors:  V A DRILL; T HIRATZKA
Journal:  AMA Arch Ind Hyg Occup Med       Date:  1953-01

9.  Toxicologic studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos.

Authors:  J Osterloh; M Lotti; S M Pond
Journal:  J Anal Toxicol       Date:  1983 May-Jun       Impact factor: 3.367

10.  Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.

Authors:  S C Hung; N I Ghali; D L Venton; G C Le Breton
Journal:  Biochim Biophys Acta       Date:  1983-02
View more
  1 in total

Review 1.  Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countries.

Authors:  Fahim Mohamed; Zoltan H Endre; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.